From the Open Medicine Foundation.
Open Medicine Foundation (OMF) is excited to announce a new collaborative study between the ME/CFS Collaborative Research Center at Uppsala, Sweden and the Harvard ME/CFS Collaboration.
This study focuses on biomarkers for long-term neurocognitive outcomes. It provides an excellent opportunity to understand the mechanism of long-lasting viral-induced cognitive complications, commonly referred to as “brain fog.” Brain fog is one of the significant symptoms of those suffering from Myalgic Encephalomyelitis/chronic fatigue syndrome (ME/CFS) and is also seen in patients with herpes simplex encephalitis (HSE).
Investigate the correlation between biomarkers for brain inflammation and long-term neurocognitive outcomes in patients with herpes simplex encephalitis (HSE).
To read the rest of this story, click on the link below: